Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 231 results for "eisai"

Eisai to Provide Diethylcarbamazine Citrate Tablets Free of Charge for Use in National Lymphatic Filariasis Elimination Campaign in Indonesia
APN News

Eisai to Provide Diethylcarbamazine Citrate Tablets Free of Ch...

Previous story: Commencing Operation at Hitachi Saudi Arabia, Ltd. Next story: Boeing, Indian Institute of Technology partner for Innovation Summit TOKYO : Eisai Co., Ltd. announced today that it has provided 151 million 100 mg tablets of ... APN News, 2 days ago
APN News

Toyota to Showcase Accessible Mobility at International Home Care and Rehabilitation Exhibition in Tokyo

Previous story: Eisai to Sponsor Lectures at Japan Research Center of Fudan University in China Next story: ASUN Solar Power participates in Renewable Energy Expo 2015 Toyota City : Toyota will debut a specially equipped vehicle featuring a ...
 APN News1 week ago Mitsubishi Heavy Industries Mechatronics Systems, Ltd. to Commence Operations under New Business Structure  APN News1 week ago Eisai to Sponsor Lectures at Japan Research Center of Fudan University in China  APN News1 week ago
Seeking Alpha

Arena: Belviq Television Ad On Hold - Market Share Slipping

Summary Marketing partner Eisai did not run any television ads in September. Belviq sales fell from about 12,000 per week to 11,000 per week in that period. Market share has slipped as well. Arena (NASDAQ: ARNA ) investors that follow ...
 Seeking Alpha6 days ago Arena: Belviq Advertising Campaign- Investors Need To Question Eisai Commitment  TeleTrader.com2 months ago Arena - Belviq Sales Dip Closer To Qsymia Than Is Comfortable  Seeking Alpha2 days ago Arena: Belviq Sales Slip In Market Share Again- Shift Focus To The Pipeline  Seeking Alpha1 week ago
Bio Spectrum Asia

Eisai, Purdue to co-develop insomnia drug

 Bio Spectrum Asia1 month ago Eisai and Purdue Pharma Enter Worldwide Collaboration to Develop and Commercialize Lemborexant  Sys-Con Media1 month ago ‘Vizag needs premier pharma research institute’  Business Line1 month ago Global Insomnia Drug Market 2015-2019  Global Information Inc1 week ago

Eisai, Halozyme ink pact to evaluate eribulin in combo with PEGPH20 in advanced breast cancer

Eisai Co., Ltd., a research-based pharmaceutical company, and Halozyme Therapeutics, Inc., a biotechnology company focused on developing and commercializing novel oncology therapies, have signed a clinical collaboration agreement to evaluate Eisai's ...
 PharmaBiz2 months ago Eisai and Halozyme Sign Collaboration Agreement to Investigate Eribulin and PEGPH20 in Metastatic Breast Cancer  Pharmacy Choice2 months ago

Eisai seeks Japanese, US & EU regulatory nods for anticancer agent, Halaven to treat soft tissue sarcoma

Eisai Co., Ltd., engaged in manufacturing and selling pharmaceutical products worldwide, has submitted applications to regulatory authorities in Japan, the United States and Europe (MHLW, FDA and EMA respectively) seeking an additional indication ...
 PharmaBiz2 months ago New Indication Sought for Eribulin (Halaven) as Treatment for Soft-Tissue Sarcoma  P&T Community2 months ago

Nikkei rises on earnings optimism; Nidec jumps on quarterly results

* Nidec jumps 10 pct on strong April-June results * Eisai tanks after Biogen drug data disappoints * Komatsu, Hitachi Construction Machinery fall beforeCaterpillar's earnings By Ayai Tomisawa TOKYO, July 23 (Reuters) - Japan's Ni
 Sify2 months ago

FDA grants Priority Review for Eisai's eribulin mesylate sNDA for soft tissue sarcoma

FDA grants Priority Review for Eisai's eribulin mesylate sNDA for soft tissue sarcoma The FDA accepts under Priority Review Eisai's (OTC:ESALF) (OTCPK:ESALY) supplemental New Drug Application (sNDA) seeking approval of eribulin mesylate ...
 TeleTrader.com1 week ago FDA Grants Eisai Inc.'s sNDA For Eribulin Priority Review Designation For The Potential Treatment Of Advanced Soft Tissue Sarcoma  BioSpace1 week ago FDA Grants Eisai's sNDA for Eribulin Priority Review Designation for the Potential Treatment of Advanced Soft Tissue Sarcoma  Sys-Con Media1 week ago

Eisai's (ESALY) Q1 2016 Results - Earnings Call Transcript

Eisai Co., Ltd. (ESALY) Q1 2016 Earnings Conference Call July 31, 2015 3:15 AM ET Executives Ryohei Yanagi - Chief Financial Officer, Chief IR Officer Hideki Hayashi - Corporate Strategy and Planning; Chief Information Officer, CEO ...
 TeleTrader.com2 months ago

Eisai Expands Magnolia Meals at Home® Program to Help People Living with Thyroid Cancer

WOODCLIFF LAKE, N.J. , Sept. 24, 2015 /PRNewswire/ -- Magnolia Meals at Home ® , a program that delivers nutritious meals at no-cost to patients living with breast cancer and their families, is now helping those living with thyroid cancer.
 SearchBug1 week ago Eisai Inc. Expands Magnolia Meals At Home Program To Help People Living With Thyroid Cancer  BioSpace1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eisai
Get updated on latest news & your favorite topics right in your inbox!
More     Less